Characterization of Tisagenlecleucel, an Anti-CD 19 CAR T Cell Product Manufactured Using T Cells from Patients with DLBCL

MOLECULAR THERAPY(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要